# The effects of Chinese botanical lotion and pimecrolimus cream in the treatment of chronic perianal eczema: a randomized clinical trial

**Authors:** Lixia Lai, Yanmei Wang, Luping Wen, Shaozhao Wang, Si Chen, Chao Gu, Zeye Zhang

PMC · DOI: 10.3389/fphar.2025.1673112 · 2025-11-12

## TL;DR

This study found that combining a Chinese herbal lotion with pimecrolimus cream improves treatment outcomes for chronic perianal eczema compared to using the cream alone.

## Contribution

The study introduces a novel combination therapy using traditional Chinese medicine and pimecrolimus for chronic perianal eczema.

## Key findings

- The treatment group showed significant improvements in eczema severity and pruritus VAS scores.
- The combination therapy had lower relapse rates and better dermatology life quality outcomes.
- Both treatments were found to be safe and reliable.

## Abstract

Fumigation and sitz-bath therapy are traditional Chinese medicine (TCM) practices that offer unique benefits for managing chronic perianal eczema (CPE). This study aimed to investigate the clinical efficacy of the traditional Chinese herbal lotion (anal pruritus lotion, APL) combined with pimecrolimus cream in CPE treatment.

Patients with CPE admitted between October 2019 and March 2022 were analyzed. The control group was given basic therapy with pimecrolimus cream, whereas the treatment group received pimecrolimus cream combined with APL under fumigation and sitz-bath therapy. We recorded and compared baseline patient information and clinical symptoms pre- and post-therapy, including clinical symptom scores, the eczema area and severity index (EASI), pruritus visual analogue scale (VAS) scores, dermatology life quality index (DLQI), and efficacy evaluations. Additionally, safety assessments and follow-up surveys were performed, as well.

Baseline data were comparable between the treatment and control groups. Post-therapy, the treatment group exhibited significantly improved outcomes compared to the control group in eczema severity, pruritus VAS scores, and dermatology life quality, with lower relapse rates (P < 0.05). Safety evaluations suggested that the treatments were safe and reliable.

The combination of pimecrolimus cream and APL is more effective in the treatment of CPE than pimecrolimus cream alone, providing a promising new approach for the clinical management of perianal eczema.

International Traditional Medicine Clinical Trial Registry, http://itmctr.ccebtcm.org.cn/en-US/Home/ProjectView?pid=58f1a168-bdf1-4e2a-a9bd-cf0f4a3ec06f as ITMCTR 2024000576.

## Linked entities

- **Chemicals:** pimecrolimus (PubChem CID 6509979)

## Full-text entities

- **Diseases:** CPE (MESH:D004485), APL (MESH:D015473), anal pruritus (MESH:D011537)
- **Chemicals:** pimecrolimus (MESH:C117268), Chinese herbal (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12647033/full.md

---
Source: https://tomesphere.com/paper/PMC12647033